Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Real Estate
Life Sciences Firm Oncorus Leases 88,184-SF in Andover, MA
Life Sciences Times
-
January 27, 2021
0
Venture Capital
Outcome Capital Advises Evergreen Systems in Its Sale to Sunstone Partners
Life Sciences Times
-
January 26, 2021
0
Pharma
Merck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Investigational Once-Monthly Oral Islatravir for the Prevention of HIV-1 Infection
Life Sciences Times
-
January 26, 2021
0
Biotech
Craig A. Hodges, Ph.D., Awarded Sensory Sentinel™ Grant by Turner Scientific
Life Sciences Times
-
January 26, 2021
0
Medtech
Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System
Life Sciences Times
-
January 25, 2021
0
Life Sciences
Babson Diagnostics First to Conduct Full Blood Panel Testing from a Finger Sample in a Retail Setting
Life Sciences Times
-
January 25, 2021
0
Public Health
Mexican President tests positive for Covid-19
Life Sciences Times
-
January 25, 2021
0
Pharma
Moderna says its Covid-19 vaccine works against new variants
Life Sciences Times
-
January 25, 2021
0
Pharma
Australia gives provisional approval to Pfizer Covid-19 vaccine
Life Sciences Times
-
January 25, 2021
0
Public Health
California Covid-19 vaccine recipient dies after inoculation
Life Sciences Times
-
January 25, 2021
0
1
...
788
789
790
...
805
Page 789 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026